Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
Sacituzumab Govitecan: First Approval
HTML
PDF
Details
Locations
Year:
2020
Type:
review
Source:
Drugs
DOI:
10.1007/s40265-020-01337-5
Author:
Yahiya Y. Syed
Institution:
Springer Nature (New Zealand)
Language:
English
Topic:
Breast Cancer Treatment Studies
Subfield:
Cancer Research
Field:
Biochemistry, Genetics and Molecular Biology
Domain:
Life Sciences
Keywords:
sacituzumab govitecan,
TROP2,
antibody-drug conjugates,
topoisomerase I inhibitor,
SN-38,
metastatic triple-negative breast cancer,
accelerated approval,
drug development milestones,
urothelial carcinoma,
brain metastases,
glioblastoma,
endometrial cancer,
prostate cancer
show all 13
SDG:
Good health and well-being
Open Access status:
bronze
Funder:
U.S. Food and Drug Administration
OpenAlex ID:
W3035644303
FWCI:
3.428
Cites:
24
Cited by:
320
Related to:
10